D-cycloserine, a partial NMDA receptor-associated glycine-B site agonist, enhances reversal learning, but a cholinesterase inhibitor and nicotine has no effect

NeuroReport

Volumn 9, Issue 16, 1998, Pages 3647-3651

  Riekkinen Jr , Paavo ^a   Ikonen, Sami ^a   Riekkinen, Minna ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's disease; Combined therapy; D cycloserine; Nicotine; Reversal learning in water maze; THA

Indexed keywords

CHOLINESTERASE INHIBITOR; CYCLOSERINE; N METHYL DEXTRO ASPARTIC ACID; NICOTINE; TACRINE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LEARNING; MALE; MAZE TEST; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTUM PELLUCIDUM; TRAINING;

EID: 15644383835     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199811160-00016     Document Type: Article

References (16)

1. Bierer LM, Haroutunian V, Gabriel S et al. J Neurochem 64, 749-760 (1995).
2. Francis PT, Bowen DM. Can J Neurol Sci 16, 504-510 (1989).
3. Knapp MJ, Knopman DS, Solomon PR et al. JAMA 271, 985-991 (1994).
4. Sahakian B, Owen AM, Morant NJ et al. Psychopharmacology 110, 395-401 (1993).
5. Braak H and Braak E. Acta Neurol Scand 165 (Suppl.), 3-12 (1996).
6. Staubli U and Lynch G. NMDA receptors and memory: evidence from pharmacological and correlational studies. In: L Silva, ed., Neurobiology of the NMDA Receptors. New York: VCH Publishers, 1991: 129-148.
7. Collingridge G and Singer W. Trends Pharmacol Sci 11, 290-296 (1990).
8. Hirotsu I, Hori N, Katsuda N et al. Brain Res 482, 194-197 (1989).
9. Aigner TG. Curr Opin Neurobiol 5, 155-160 (1995).
10. Flood JF, Morley JE and Lanthorn TH. Eur J Pharmacol 221, 249-254 (1992).
11. Hagan JJ and Morris RGM. The cholinergic hypothesis of memory: a review of animal experiments. In: Iversen LL and Iversen SD, eds. Handbook of Psychopharmacology. New York: Plenum Press, 1989: 237-323.
12. Sirviö J, Ekonsalo T, Riekkinen P Jr et al. Neurosci. Lett. 146, 215-218 (1992).
13. Riekkinen P Jr, Ikonen S and Riekkinen M. NeuroReport 9, 1633-1637 (1998).
14. Riekkinen P Jr, Sirviö J and Riekkinen P. Pharmacol Biochem Behav 36, 237-241 (1990).
15. Riekkinen P Jr, Sirviö J and Riekkinen M. Brain Res 662, 95-102 (1994).
16. Searle clinical research report. Report No. NC6-93-06-009, September 29. Skokie, IL; GD Searle (1993).